• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about PTGX

Recent news which mentions PTGX

< Previous 1 2 3 4 Next >
Mid-Day Market Update: Nasdaq Down 400 Points; Arch Resources Shares Jump
April 26, 2022
Tickers ARCH CENN EDN KEN
Tags TZOO NEXT Penny Stocks
From Benzinga
34 Stocks Moving In Tuesday's Mid-Day Session
April 26, 2022
Tickers ACON AGRX ARCH AVDL
Tags News FFIE ERYP
From Benzinga
Mid-Morning Market Update: Markets Open Lower; Dow Dips 300 Points
April 26, 2022
Tickers AVDL INDO JCSE MX
Tags PHX Intraday Update AVDL
From Benzinga
Why Protagonist Therapeutics Shares Are Crashing Today
April 26, 2022
Tickers PTGX
Tags Trading Ideas Health Care Movers
From Benzinga
The Daily Biotech Pulse: Protagonist's Ulcerative Colitis Study Disappoints, Gilead's Remdesivir Approved For Pediatric COVID-19 Patients, FDA Gives Nod To Gamida's Cell Therapy Trial, Fast Track Tag
April 26, 2022
Tickers AGRX AMAM BGNE GILD
Tags PTGX IBB Benzinga
From Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
April 26, 2022
Tickers AGRX AVDL BBLG ERYP
Tags Movers TTNP ETTX
From Benzinga
18 Stocks Moving in Tuesday's Pre-Market Session
April 26, 2022
Tickers AGRX AIM ALZN AVDL
Tags Top Gainers Benzinga INM
From Benzinga
Protagonist Therapeutics Topline Data from Phase 2 IDEAL Study of PN-943 (450 mg BID) Miss Primary Endpoint
April 25, 2022
Tickers PTGX
Tags Market News Biotech General
From Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
April 20, 2022
Tickers BSGM CLSN ENDP KTRA
Tags CLSN XLO LYRA
From Benzinga
51 Biggest Movers From Thursday
April 18, 2022
Tickers AIRG AMST APCX AREB
Tags PHAS CRDL GFAI
From Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
April 14, 2022
Tickers BFRI CLRB HSTO ISO
Tags BFRI Market News LYRA
From Benzinga
The Daily Biotech Pulse: Pfizer-BioNTech COVID-19 Booster Data In Kids, Regeneron's COVID-19 Therapy Decision Pushed, Protagonist's Rusfertide Breakthrough Tag Update And More
April 14, 2022
Tickers ABBV AMRX BNTX BYSI
Tags PFE Covid/19 Biotech
From Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
April 14, 2022
Tickers AGRX AIM AIRG APLD
Tags AIRG CBAT AIM
From InvestorPlace
FDA Intends To Revoke Protagonist Therapeutics' Rusfertide Breakthrough Tag In Rare Form Of Blood Cancer
April 14, 2022
Tickers PTGX
Tags General PTGX Benzinga
From Benzinga
Protagonist Therapeutics Earns $25M Milestone Payment From Janssen Biotech
March 16, 2022
Tickers JNJ PTGX
Tags Biotech Health Care Small Cap
From Benzinga
Protagonist Therapeutics's Return On Capital Employed Overview
March 03, 2022
Tickers PTGX
Tags BZI/ROCE Market News Earnings
From Benzinga
3 Desirable Drug Stocks With Very Promising Pipelines
February 16, 2022
Tickers AGIO BMY HRMY JNJ
Tags SDGR NASDAQ:HRMY,NASDAQ:SDGR,NASDAQ:PTGX,NYSEARCA:XBI,NASDAQ:SNY,NYSE:BMY,NASDAQ:AGIO,NYSE:JNJ Hot Stocks
From InvestorPlace
The Week Ahead In Biotech (Dec. 6-Dec. 11): Daré FDA Decision, Adcom Tryst For Reata, Multiple Conference Presentations And More
December 06, 2021
Tickers ABBV ADCT AGIO ALNY
Tags CTIC ALNY ATNM
From Benzinga
Protagonist To Go Ahead With Oral Peptide PN-235, Discontinues Phase 1 Candidate
December 03, 2021
Tickers JNJ PTGX
Tags Biotech Trading Ideas Health Care
From Benzinga
The Daily Biotech Pulse: Protagonist Pulls Plug On Phase 1 Asset, Xenon Aces Mid-Stage Epilepsy Study, Esperion Prices Offering
December 03, 2021
Tickers BGNE BMY ESPR IBB
Tags ESPR MRK Biotech
From Benzinga
What 9 Analyst Ratings Have To Say About Protagonist Therapeutics
November 15, 2021
Tickers PTGX
Tags PTGX BZI/AAR Benzinga
From Benzinga
The Week Ahead In Biotech (Nov. 7-Nov. 13): Earnings Taper Off, Multiple Conference Presentations, IPOs And More
November 08, 2021
Tickers ABUS ACAD ACIU ADAP
Tags Earnings IPOs OCUP
From Benzinga
Why Protagonist Therapeutics Stock Skyrocketed 80.2% Last Month
November 08, 2021
Tickers PTGX
Tags Recent Press Releases Market News PTGX
From Motley Fool
5 Short Squeeze Candidates To Watch: Progenity Tops List Again, Augmented Reality Play WiMi Hologram Joins List
November 01, 2021
Tickers AMC ASLE BTBT GLG
Tags Stocks To Watch NXTD Short Sellers
From Benzinga
Short Squeeze Stocks: PTGX, AGC and 3 Others Experts Think Are Ready to Pop
October 25, 2021
Tickers AGC DBGI PALT PROG
Tags DBGI Uncategorized Market News
From InvestorPlace
5 Short Squeeze Candidates To Watch: Progenity, Digital Brands Top List Again, SPAC AGC Joins Ahead Of Merger
October 25, 2021
Tickers AGC AMC DBGI GME
Tags SPACs Stocks To Watch DBGI
From Benzinga
The Daily Biotech Pulse: Athira CEO Resigns Over Doctored Research, Merck's Keytruda Snags First Approval For Breast Cancer In Europe, Minerva And Xilio IPOs
October 22, 2021
Tickers ADPT ATHA AVRO IBB
Tags RHHBY Benzinga SNY
From Benzinga
The Week Ahead In Biotech (Oct. 18-23): J&J, Biogen Kickstart Big Pharma Earnings, Regeneron-Sanofi, Roche Await FDA Decisions And IPOs
October 18, 2021
Tickers ABEO ABT AVDL AVRO
Tags JSPR SIOX UTRS
From Benzinga
Ten stocks worth watching next week
October 16, 2021
Tickers AA ADMP FCEL MFH
Tags AA OEG FCEL
From AC Investor Blog
What 10 Analyst Ratings Have To Say About Protagonist Therapeutics
October 13, 2021
Tickers PTGX
Tags Market News Benzinga BZI/AAR
From Benzinga
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap